Dayana G. Bajburdyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dayana G. Bajburdyan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Aishan Е. Ibaduiiaeva
Pavlov First St. Petersburg State Medical University
1 shared publication - Anastaiya N. Nikovaeva
Novgorod State University
1 shared publication - Anastasiya V. Fayans
Pirogov Russian National Research Medical University
1 shared publication - Anna A. Kosova
I.M. Sechenov First Moscow State Medical University
1 shared publication - Daria V. Zyuzina
Kirov Military Medical Academy
1 shared publication - Dmitriy V. Kaiinin
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
1 shared publication
Latest Publications
- Open Access
- 26 December 2024
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 21 (6) , 520-533
Modern Possibilities of Usage Dupilumab in Children
Dupilumab is a genetically engineered immunobiological drug that has been increasingly used in recent years to treat bronchial asthma (BA), atopic dermatitis (AD) and eosinophilic esophagitis (EE) in children. The aim of the study is to analyze current literature data on the use of dupilumab in the treatment of BA, AD and EE in children. Despite the short history of dupilumab use in the pediatric population, its usage has shown promising results in the treatment of many conditions whose pathogenesis is T2 inflammation, primarily BA, AD and EE. It has demonstrated efficacy in patients with various clinical manifestations characterized by moderate to severe course or refractory to treatment, and has led to an improvement in the quality of life of patients. With the expansion of the use of dupilumab, there is more and more evidence of its usefulness in the treatment of other T-cell-mediated diseases.
- 26 December 2024
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 21 (6) , 520-533
Open AccessModern Possibilities of Usage Dupilumab in Children
Dupilumab is a genetically engineered immunobiological drug that has been increasingly used in recent years to treat bronchial asthma (BA), atopic dermatitis (AD) and eosinophilic esophagitis (EE) in children. The aim of the study is to analyze current literature data on the use of dupilumab in the treatment of BA, AD and EE in children. Despite the short history of dupilumab use in the pediatric population, its usage has shown promising results in the treatment of many conditions whose pathogenesis is T2 inflammation, primarily BA, AD and EE. It has demonstrated efficacy in patients with various clinical manifestations characterized by moderate to severe course or refractory to treatment, and has led to an improvement in the quality of life of patients. With the expansion of the use of dupilumab, there is more and more evidence of its usefulness in the treatment of other T-cell-mediated diseases.
- Open Access
- 13 October 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 26 (9) , 557-561
Features of the nasal microbiota in patients with allergic rhinitis: A review
The article analyzes the data of modern literature on the microbiota of ENT organs in normal and pathological conditions. The microbiota plays an important role in maintaining homeostasis by influencing metabolism, the immune system and human physiology. This complex of microorganisms includes bacteria, viruses and fungi that form the biofilm of otolaryngological organs, which prevents the penetration of pathogenic microorganisms. Different parts of the human upper respiratory tract have similar types of bacteria, but it differs dramatically at the level of families and genera. In addition, the balance of microbial flora depends on the immune system status, environmental factors, medication intake, age, race, lifestyle, as well as the health of other ENT organs. Changes in the nasal mucosa in allergic rhinitis are often associated with an increase in the content of bacteria. For example, Staphylococcus aureus can cause more severe nasal congestion in conjunction with protracted rhinitis and sinusitis. The production of bacterial proteinases contributes to easier penetration of allergens and activation of mucosal cells. The absence of microbiota can increase the response of the immune system and reduce the number of cells that contribute to the regulation of inflammation. This review presents an analysis of the composition of the normal microflora of otolaryngological organs and its effect on the occurrence of allergic rhinitis.
- 13 October 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 26 (9) , 557-561
Open AccessFeatures of the nasal microbiota in patients with allergic rhinitis: A review
The article analyzes the data of modern literature on the microbiota of ENT organs in normal and pathological conditions. The microbiota plays an important role in maintaining homeostasis by influencing metabolism, the immune system and human physiology. This complex of microorganisms includes bacteria, viruses and fungi that form the biofilm of otolaryngological organs, which prevents the penetration of pathogenic microorganisms. Different parts of the human upper respiratory tract have similar types of bacteria, but it differs dramatically at the level of families and genera. In addition, the balance of microbial flora depends on the immune system status, environmental factors, medication intake, age, race, lifestyle, as well as the health of other ENT organs. Changes in the nasal mucosa in allergic rhinitis are often associated with an increase in the content of bacteria. For example, Staphylococcus aureus can cause more severe nasal congestion in conjunction with protracted rhinitis and sinusitis. The production of bacterial proteinases contributes to easier penetration of allergens and activation of mucosal cells. The absence of microbiota can increase the response of the immune system and reduce the number of cells that contribute to the regulation of inflammation. This review presents an analysis of the composition of the normal microflora of otolaryngological organs and its effect on the occurrence of allergic rhinitis.